IceCure Medical Ltd ICCM
Set alert
At close · Oct 30
After hours · Oct 30, 7:27 PM ET
- YTD
- -95.25%
- 1 year
- -95.92%
- Open
- 0.94
- Prev close
- 0.9284
- Mkt cap
- 4.04M
- Vol
- 50.15K
- Avg vol
- 145.54K
- EPS
- -6.84
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8201
- High
- 0.951
- Forward P/E
- -4.48
- Beta
- 2.63
- Short ratio
- 0.46
- Inst. own
- 0.40%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 20, 2024
- 50-d avg
- 0.74766
- 200-d avg
- 0.852735
- 1y target
- 3.37
News
-
5 days ago benzinga.com
IceCure Medical Completes Treatment Of First Patient In Its Post-Marketing Study Evaluating ProSense Cryoablation For Local Treatment Of Low-Risk Breast Cancer
First patient enrolled and treated at West Cancer Center in Tennessee, USACAESAREA, Israel, Oct. 27, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure," "IceCure Medical" or the
5 days ago prnewswire.com
IceCure Successfully Completes First Cryoablation Treatment in Its ChoICE Post-Marketing Study for Breast Cancer Cryoablation
First patient enrolled and treated at West Cancer Center in Tennessee, USA CAESAREA, Israel, Oct. 27, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the…
1 week ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers SCWorx (NASDAQ:WORX) stock rose 47.8% to $3.96 during Tuesday's pre-market session. Integra Lifesciences (NASDAQ:IART) shares increased by 31.97% to $17.75. The market value of their…
1 week ago prnewswire.com
IceCure Enrolls First Patients in Its FDA-Approved Study for ProSense® Breast Cancer Cryoablation at Two U.S. Sites
CAESAREA, Israel, Oct. 20, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that…
2 weeks ago defenseworld.net
Nexalin Technology (NASDAQ:NXL) vs. IceCure Medical (NASDAQ:ICCM) Financial Analysis
Nexalin Technology (NASDAQ: NXL - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast…
-
2 weeks ago benzinga.com
IceCure Medical Announces Presentations, Posters And Physician Workshops On Its ProSense Breast Cancer Cryoablation At The European Society Of Breast Imaging Annual Scientific Meeting
Featured presentations included 12-month clinical data reporting objective response rates of 97.5% among 40 patients treated with cryoablation plus endocrine therapy and 91.7% among 24 patients…
2 weeks ago prnewswire.com
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
Scientific presentations, research posters and clinical workshops featured ProSense® breast cancer cryoablation and highlighted strong physician engagement across Europe CAESAREA, Israel, October 13,…
-
3 weeks ago benzinga.com
IceCure Medical Adds Legacy Health In Portland, Oregon, As New U.S. Clinical Site For Its Post-Marketing ChoICE Study Evaluating Prosense Cryoablation For Treatment Of Low-Risk Breast Cancer
Adds Legacy Health in Portland, Oregon, with its Legacy Medical Group–Surgical Oncology at Good Samaritan Medical Center , as a new U.S. clinical site for its post-marketing study (the "ChoICE…
3 weeks ago prnewswire.com
IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
CAESAREA, Israel, Oct. 6, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that…
1 month ago defenseworld.net
IceCure Medical Ltd. (NASDAQ:ICCM) Stock Now Rated “Hold” by Sell-Side Analysts
Shares of IceCure Medical Ltd. (NASDAQ: ICCM - Get Free Report) have been given an average recommendation of "Hold" by the five research firms that are covering the firm, MarketBeat.com reports. Two…
1 month ago defenseworld.net
Reviewing IceCure Medical (NASDAQ:ICCM) & Precision Optics (NASDAQ:POCI)
Precision Optics (NASDAQ: POCI - Get Free Report) and IceCure Medical (NASDAQ: ICCM - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two…
1 month ago benzinga.com
Full Transcript: Icecure Medical Q2 2026 Earnings Call
Icecure Medical (NASDAQ:ICCM) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered by Benzinga APIs. For…
1 month ago zacks.com
IceCure Secures China NMPA Approval for ProSense Cryoablation System
ICCM's NMPA approval for ProSense opens China to commercialization, expanding its global regulatory footprint and long-term revenue opportunity.
-
1 month ago benzinga.com
IceCure Medical Receives Approval From China's National Medical Products Administration For Its ProSense System, Associated Cryoprobes
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to
1 month ago prnewswire.com
IceCure Medical Receives Regulatory Approval to Market ProSense® in China
CAESAREA, Israel, Sept. 10, 2026 /PRNewswire/ -- IceCure Medical Ltd.
-
2 months ago benzinga.com
IceCure Medical Inks Distribution Agreement With Scovas Medical To Distribute IceCure's ProSense Cryoablation Systems In Netherlands
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to
2 months ago prnewswire.com
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
Agreement expands ProSense® commercialization in the Netherlands as cryoablation advances to Phase III in the Netherlands-based independent THERMAC breast cancer cryoablation trial after achieving…
-
2 months ago benzinga.com
IceCure Medical Says JHM-IRB Of West Cancer Center & Research Institute In Germantown, Tennessee, Approves Post-Marketing Study For ProSense Cryoablation In Local Treatment Of Low-Risk Breast Cancer
Patients are expected to enroll in the post-marketing study in the coming weeks, following approval from the Institutional Review Board of West Cancer Center & Research Institute in Germantown,…
2 months ago prnewswire.com
West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
Patients are expected to enroll in the post-marketing study in the coming weeks, following approval from the Institutional Review Board of West Cancer Center & Research Institute in Germantown, TN…
-
2 months ago benzinga.com
IceCure Medical Highlights Peer‑Reviewed Publications Reinforcing Cryoablation’s Growing Clinical Role In Breast Cancer Treatment De‑Escalation, Including FDA Authorization Of ProSense, Updated ASBrS Guidelines, And Positive ICE3 5‑Yr Outcomes
New review by leading U.S. experts highlights ProSense® FDA marketing authorization, updated American Society of Breast Surgeons guidelines, and encouraging outcomes from the five-year ICE3 clinical…
2 months ago prnewswire.com
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
New review by leading U.S. experts highlights ProSense® FDA marketing authorization, updated American Society of Breast Surgeons guidelines, and encouraging outcomes from the five-year ICE3 clinical…
2 months ago seekingalpha.com
IceCure Medical Ltd (ICCM) Q2 2026 Earnings Call Transcript
IceCure Medical Ltd (ICCM) Q2 2026 Earnings Call Transcript
-
2 months ago benzinga.com
Icecure Medical Q2 EPS $(1.37) Beats $(1.40) Estimate, Sales $889.000K Miss $1.450M Estimate
Icecure Medical (NASDAQ:ICCM) reported quarterly losses of $(1.37) per share which beat the analyst consensus estimate of $(1.40) by 2.14 percent. This is a 23.89 percent increase over losses of…
2 months ago prnewswire.com
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
The Company is advancing commercial execution and expanding its U.S. commercial footprint through approximately 70% growth in its active installed base following U.S. Food and Drug Administration's…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's after-market session. The company's market cap stands at $1.9 billion. As per the news, the Q2 earnings…
2 months ago prnewswire.com
IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
Adventist Health Glendale is the first site able to enroll patients in the ChoICE Study after signing both an agreement and receiving IRB approval The site will be led by breast surgeon, Dr. Dennis…
2 months ago prnewswire.com
IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026
CAESAREA, Israel, Aug. 5, 2026 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that…
-
3 months ago benzinga.com
IceCure Medical Announces That The Society Of Interventional Oncology Submitted A Petition To The National Comprehensive Cancer Network Breast Cancer Guidelines Panel To Include Percutaneous Cryoablation Without Surgical Excision As An Option For Breast Cancer
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to
3 months ago prnewswire.com
IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
The petition by The Society of Interventional Oncology (SIO) includes adding criteria for patients aged 50-69 who are poor surgical candidates or who decline surgery in the National Comprehensive…
3 months ago prnewswire.com
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
Company signed agreement with the West Cancer Center & Research Institute, the first clinical site for its post-marketing study for ProSense® cryoablation in the treatment of low-risk breast cancer…
3 months ago prnewswire.com
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
CAESAREA, Israel, July 14, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive liquid nitrogen-based cryoablation…
-
3 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-market session. The company's market cap stands at $11.0 million. BioRestorative Therapies (NASDAQ:BRTX)…
-
3 months ago benzinga.com
IceCure Medical Notes Growing International Interest In Its ProSense System In Brazil
Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding interventional oncology markets increased following FDA authorizationIndependent study evaluating breast cancer…
3 months ago prnewswire.com
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding interventional oncology markets increased following FDA authorization Independent study evaluating breast cancer…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers INVO Fertility (NASDAQ:IVF) shares moved upwards by 67.3% to $2.08 during Friday's regular session. The market value of their outstanding shares is at $2.2 million. The company's, Q1 earnings…
4 months ago benzinga.com
What's Going On With IceCure Medical Stock On Friday?
IceCure Medical (NASDAQ: ICCM) has officially regained compliance with Nasdaq's minimum bid price requirement. Read the details.
-
4 months ago benzinga.com
IceCure Medical Regains Nasdaq Compliance
IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Pulsenmore (NASDAQ:PLSM) shares moved upwards by 160.5% to $8.88 during Wednesday's regular session. The market value of their outstanding shares is at $22.1 million. Icecure Medical…
4 months ago benzinga.com
KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On Wednesday
U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares jumped 16.2%. Other big gainers: WEN, ABSI, RUN, CCXI, ENRD, SFTX, ICCM, INMD, DFH.
-
4 months ago benzinga.com
IceCure Medical Highlights Newly Published Peer-Reviewed Journal Article Presenting Key Clinical Advantages Of Cryoablation Over Radiofrequency Ablation For Early-Stage Breast Cancer
Published in the International Journal of Surgery, globally ranked in the top three among surgery journals, the article highlights strong clinical outcomes with ProSense® cryoablation and describes…
4 months ago benzinga.com
Apogee Therapeutics, Definium Therapeutics, Baldwin Insurance And Other Big Stocks Moving Higher On Monday
U.S. stocks up with Dow Jones gaining 200+ points. AbbVie Inc. announced acquisition of Apogee Therapeutics for $10.9B. Other gaining stocks include DFTX, HIVE, SSTK, BWIN, ICCM, ORKA, CHRN, UMC,…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
4 months ago benzinga.com
Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Smith & Wesson (SWBI) shares rose in pre-market trading after posting strong Q4 results, beating earnings and revenue estimates. Other gainers include LNKS, ADTX, and SPRO.
4 months ago benzinga.com
Smartbird, Nebius Group, IceCure Medical, Robinhood And Meta: Why These 5 Stocks Are On Investors' Radars Today
Major U.S. stock indexes closed lower on Wednesday, with the Dow Jones Industrial Average slipping 0.98% to 51,942.55.
-
4 months ago benzinga.com
IceCure Medical Commences ~$5.5M Offering Of Ordinary Shares, Pre-Funded Warrants At Combined Price Of $3/Share
IceCure Medical Ltd. (NASDAQ:ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical…
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
4 months ago benzinga.com
IceCure Stock Surges After 70% ProSense Install Increase
IceCure Medical shares are soaring Wednesday after reporting a 70% jump in U.S. installs of its ProSense breast cancer cryoablation system.
4 months ago benzinga.com
Crude Oil Edges Higher; US Retail Sales Top Estimates
U.S. stocks up, Dow Jones gains 0.39%. NASDAQ rose 0.09%, S&P 500 up 0.11%. Industrials shares jump 0.9%, while communication services fall 1.7%.
4 months ago benzinga.com
US Stocks Edge Higher; CarMax Posts Upbeat Earnings
US stocks gain in morning trading, Dow up 0.1%. Tech sector leads gains, while communication services fall. CarMax beats earnings expectations.
-
4 months ago benzinga.com
IceCure Medical Reports 70% Growth In U.S. ProSense Install Base Following FDA Clearance
Increase driven by FDA clearance, clinical guideline support, and increased physician demand. Significant rise in number of leads for ProSense® systems generated at U.S. medical society conferences…